cipla ltd for brief case analysis
TRANSCRIPT
-
8/12/2019 CIPLA LTD for Brief case analysis
1/10
CIPLA LTD
Latest Results (Rs Cr)
Period-Ended Dec-13 Dec-12 Var [%
Sales2,253.2
02,039.5
9 10.47OtherIncome 53.08 53.48 -0.75
PBIDT 45.02 54.37 -1.54
PBDT 427.72 537.07 -20.3
PBIT 373.94 48.37 -20.1
PBT 345.4 459.07 -24.71
!P"T 20.77 338.78 -23.03
#P"T 0 0 0
"P"T 20.77 338.78 -23.03
$P 342.85 41.78 -17.74
!ar"et Data (As on #rida$ #e&ruar$ 2' 21 )
Pr%ce &!s' 384.35 52 ( )*+&!s'450 *
354.4
+at. #PS&!s' 17.18 +at. P*# 22.37
t. $a.&!s $r' 30859.5 +at.#/t &!s $r' 10.58
+at. B&!s' 110.3 D%. %el &' 0.52
Stoc oement
!at%n6 Date Secr%t Te "mont &$r.' !at%n6 02-12-2013 +on6 Term Dets 72.38 """ 02-12-2013 Short Term Det 1723.5 "1 24-09-2013 :on-$onert%le Deentres 2000 In """
*+are+oldin, Pattern
&"S O: Dec 2013' Shares ;ot )ol%n6 0 0
:on Promoter $or.)ol.
41,259,301.00 5.14
Promoters295,485,978.
00 3.8
Pl%c ? Others153,252,08.
00 19.09
-
8/12/2019 CIPLA LTD for Brief case analysis
2/10
29-04-2013 $ommerc%al Paer*Short Term Det 1000 "1&%n' 29-04-2013 $ommerc%al Paer*Short Term Det 1000 "1&%n' 12-03-2013 +on6 Term Dets 72.38 """
12-03-2013 Short Term Det 1723.5 "1 28-02-2013 Short Term Det 1723.5 "1
28-02-2013 +on6 Term Dets 72.38 """
08-02-2013 +on6 Term Dets 8. """
08-02-2013 Short Term Det 1723.5 "1
=%nanc%al )%6hl%6hts
@2=13
@3=13 @2 = 14
@3=14
Oerat%n6 Income2,198.
02,079.3
8 2,347.442,281.5
8
>roAth &O' - - .77 9.72
OPBDIT 75. 492.89 552.93 402.94
+ess Derec%at%on 73.9 78 81.5 82.08
+ess Interestchar6es 4.01 9.3 33.1 28.3
Other Income 4.14 53.48 4.52 53.08#Ccet%onal>a%n*+oss - - - -
PBT 1.77 459.07 502.19 345.4
+ess TaC 11.7 120.29 12.1 84.87
P"T &$oncernShare' 500.01 338.78 37.03 20.77
OPBDIT*OI 30.73 21.0 23.55 17.
P"T*OI 22.74 14.85 1.02 11.43
$oman Pro%le
$%la +%m%te &$%la' %s one o the lea%n6 harmacet%cal coman %n the omest%c ormlat%ons
se6ment A%th a maret share o E5. In a%t%on to %ts stron6 resence %n the In%an maret, the
coman 6enerates nearl 55 o %ts trnoer rom eCorts to ar%os emer6%n6 an re6late
marets. In the omest%c ormlat%ons maret, $%la has art%clarl stron6er resence %n ant%-
%nect%e an res%rator se6ment. (%th%n res%rator, %t commans oer 75 share o %nhalers %n
In%a. Oer the ast three ears &=09-11', the 6roAth %n $%laFs omest%c ormlat%ons at
-
8/12/2019 CIPLA LTD for Brief case analysis
3/10
12.0 has een eloA the %nstr aera6e lar6el e to %ts h%6her resence %n some o the
matre rocts as Aell as re 6ener%c se6ments an comarat%el loAer resence %n ast-
6roA%n6 chron%cs l%e $S an "nt%-D%aet%c.
In the eCorts maret, $%la oerates thro6h artnersh%s ase s%ness moel, Ahere%n %t
eelos an manactres the rocts an rece%es l%cens%n6 %ncome an manactr%n6
reenes. The comanFs eCorts trnoer has 6roAn at a $">! &' o 17 oer the ast %e
ears. The "r%can re6%on %s maGor maret or the coman olloAe HS an #roe. To
stren6then %ts resence %n the eCorts maret, $%la %s tar6et%n6 the %nhalers se6ment %n #roe
A%th a aset o 11 rocts. >%en the h%6h entr arr%ers &e to relat%el lon6er aroal
t%me rames', the %nhalers se6ment aces relat%el l%m%te comet%t%on comare to re an%lla
6ener%cs an oer lcrat%e oortn%t or $%la to ram %ts resence %n the #roean
marets. (%th recentl eCane caac%t%es &at Inore S#', 6roA%n6 aroals %n the %nhalers
%n #roe an other non-HS marets, the coman %s l%el to re6%ster stron6 6roAth %n oerseas
marets 6o%n6 orAar.
Peror.ance /0er0ie
The $omanFs reene rom oerat%ons r%n6 the %nanc%al ear 2012-13 amonte to !s.
8,295 crore a6a%nst !s. 7,075 crore %n the re%os ear recor%n6 a 6roAth o more than 17
ercent. The omest%c trnoer %ncrease more than 14 ercent, rom J3,213 crore %n the
re%os %nanc%al ear to !s.3,81 crore %n the %nanc%al ear ner re%eA. Total eCorts
%ncrease aot 20 r%n6 the ear to !s.4,42 crore. Dr%n6 the ear ner re%eA,
oerat%n6 mar6%n %ncrease 34 ercent. Th%s Aas r%mar%l e to rect%on %n mater%al cost
on accont o %mroe real%sat%ons, chan6es %n the roct m%C an h%6her contr%t%on o
#sc%taloram %n the HS. "s a reslt, ro%t ater taC %ncrease more than 34 ercent to J1,507
crore rom J1,124 crore %n the re%os %nanc%al ear.
In orer to %l a stron6 onat%on or tre 6roAth, $%la lanche Kaa6rt%, the
transormat%on ro6ramme, r%n6 the ear ner re%eA. The ro6ramme %s a%me at rec%n6
s%ness comleC%t an stren6then%n6 oerat%ons. $%la rat%onal%Le %ts eCosre to seeral loA
ale marets an artners to rece comleC%t.
"%t%onall, on-t%me-%n-ll el%er leels %mroe tAo to threeol thro6h e%cate eort %n
the sl cha%n rocesses. The %mact o these %n%t%at%es has alrea een reco6n%Le
seeral e artners AorlA%e.
"nother cr%t%cal ocs o th%s ro6ramme %s to %mroe cost eect%eness across rocts Ah%le
hol%n6 the h%6hest stanars o re6lator, /al%t an saet re/%rements. Kaa6rt%Fs eorts
hae rece %el loss, shortene lea t%mes an eottlenece constra%ne caac%t%es
across manactr%n6 ac%l%t%es %mlement%n6 seeral %mroement %eas.
The $oman has recentl also lanche MProcrement #ect%eness #ortF to %l est %n
class rocrement ract%ces an rther real%Le cost sa%n6s.
-
8/12/2019 CIPLA LTD for Brief case analysis
4/10
-
8/12/2019 CIPLA LTD for Brief case analysis
5/10
-
8/12/2019 CIPLA LTD for Brief case analysis
6/10
ranules India Ltd
Latest Results (Rs Cr)
Period-Ended Dec-13 Dec-12 Var [%
Sales 22.12 173.9 50.8
OtherIncome 0.31 0.37 -1.22
PBIDT 45.32 17.14 14.41
PBDT 41.01 12.8 223.42
PBIT 38.5 12.2 215.25
PBT 34.35 7.8 340.38
!P"T 22.99 5.43 323.39
#P"T 0 0 0
"P"T 22.99 5.43 323.39
$P 29.5 10.31 187.58
!ar"et Data (As on !onda$ !arc+ 1 21 )
Pr%ce &!s' 28.85 52 ( )*+&!s' 294 * 90.15
+at. #PS&!s' 32.57 +at. P*# 8.25
t. $a.&!s$r' 545.23
+at.#/t &!s$r' 20.28
*+are+oldin, Pattern
&"S O: Dec 2013' Shares ;ot )ol%n6 0 0
:on Promoter $or.)ol. 32,909.00 3.12
Promoters9,909,974.0
0 48.8
Pl%c ? Others4,327,077.0
0 21.33
-
8/12/2019 CIPLA LTD for Brief case analysis
7/10
+at. B&!s' 133.4 D%. %el &' 0.74
Stoc oement
$re%t !at%n6
!at%n6 Date Secr%t Te"mont&$r.' !at%n6
27-12-2013 Det Pro6amme 5 "2
27-12-2013 Det Pro6amme . BBB
27-12-2013 Det Pro6amme 12.4 BBB
27-12-2013 Det Pro6amme 125.34 "2
27-12-2013 Det Pro6amme 257.32 "2
27-12-2013 +on6 Term Dets 1.38 BBB
19-11-2013 +on6 Term Dets 1.87 BBB
19-11-2013 +on6 Term Dets . BBB
19-11-2013 Short Term Det 137.98 "2 19-11-2013 Short Term Det 250.72 "2
08-11-2013 Det Pro6amme 5 "2
08-11-2013 +on6 Term Dets 1.38 BBB
08-11-2013 Det Pro6amme 257.32 "2
08-11-2013 Det Pro6amme 125.34 "2
08-11-2013 Det Pro6amme 12.4 BBB
08-11-2013 Det Pro6amme . BBB
11-09-2013 +on6 Term Dets 1.38 BBB
11-09-2013 +on6 Term Dets 5 BBB
11-09-2013 +on6 Term Dets . BBB 11-09-2013 Short Term Det 257.32 "2
11-09-2013 Short Term Det 125.34 "2
11-09-2013 +on6 Term Dets 12.4 BBB
05-09-2013 +on6 Term Dets 259.19 BBB
05-09-2013 Short Term Det 137.98 "2
-
8/12/2019 CIPLA LTD for Brief case analysis
8/10
#inancial i,+li,+ts
@2 =13 @3 =13 @2 = 14 @3 =14
Oerat%n6 Income 17.84 173.9 239 22.13
>roAth &O' - - 42.40 50.8
OPBDIT 20.0 17.14 35.2 45.32+ess Derec%at%on 5.0 4.88 5.4 .+ess Interestchar6es 4.07 4.4 4.14 4.3
Other Income 0.15 0.37 0.41 0.31
#Ccet%onal>a%n*+oss - - - -
PBT 11.08 8.17 2.49 34.7
+ess TaC 3.14 2.37 8.83 11.3P"T &$oncernShare' 7.94 5.8 17. 23.31
OPBDIT*OI 11.95 .54 14.90 17.29P"T*OI 4.73 2.21 7.39 8.89
Co.4an$ Proile
Incororate as a r%ate l%m%te coman %n 1991, >ranles In%a &>I+' Aas conerte %nto a
l%c l%m%te coman %n =e.N93. It commence %ts oerat%ons %n "r.N91 as a merchant
eCorter o l r6s l%e aracetamol, 6a%enes%n an chloro hen%ram%ne maleate. The
coman eCorts to the HS, #roe, eC%co an )on6on6. S%nce 1992, >I+ concentrate on
eCort o aracetamol oAer. In "6.N94, >I+ too oer Tr%ton +aorator%es &T+', a 6ro
coman rom Ah%ch >I+ Aas rocr%n6 the r6s or eCorts. >I+ also ac/%re a s%c n%tAh%ch Aas manactr%n6 l r6s, rom the "nhra Praesh State =%nanc%al $ororat%on
&"PS=$' %n ar.N94.
>I+ %mlemente the on6o%n6 roGect taen oer rom T+ to manactre l r6s l%e ol%c
ac%, saltamol slhate, rom hen%ram%ne maleate an %rect comress%on &D$' lens o
aracetamol, thro6h the rocess o 6ranlat%on. The n%t, an #OH, %s locate at )eraa,
"nhra Praesh. $ommerc%al roct%on o ol%c ac% commence %n "6.N95. It came ot A%th a
l%c %sse %n Se.N95 to art-%nance th%s roGect.
$oman has comlete eCans%on o >a%enes%n caac%t rom 100 ts to 240 ts er
annm. $oman ha eelo%n6 neA rocts l%e Brom Phen%ram%ne aleate ? $hloroPhen%ram%ne aleate, ? %s %n rocess o eelo%n6 neA l r6 or the eCort maret.
$oman %s er mch hoel aot comanNs erormance e to eCans%on o roGect A%ll
e comlete %n the crrent ear.
The $oman set a 100 maret%n6 ss%%ar %n HS to enhance %ts eCosre %n the lar6e
harmacet%cal maret %n the Aorl. The >a6%llar lant commences %ts commerc%al roct%on
o +%ne II&%nstalle caac%t 3200 T' Ah%ch Aas commence %ts Kl,2003 an the rema%n%n6
-
8/12/2019 CIPLA LTD for Brief case analysis
9/10
4000 TP" %s eCecte to 6o on stream %n the %rst hal o 2003-04. The total roGect cost %s
!s.30 crore.
Peror.ance /0er0ie
The $oman ha ole-%6%t 6roAth %n all three roct se6ments, "PIs, P=Is an =%n%she
Dosa6es. (h%le all the se6ments 6reA, the "PI se6ment const%tte the lar6est ort%on o the
reene m%C %n =13. De to the ela %n the =ormlat%on #Cans%on, more "PIs Aere sol
%nstea o e%n6 se or cat%e consmt%on. The $oman sol a lar6e ort%on o %ts "PI %n
the omest%c maret %n =13 Ah%ch le to an %ncrease %n oerall omest%c sales. The $oman
has stron6 acorers or %ts =ormlat%on D%%s%on an eCects an %ncrease %n sales %n =14
once the neA caac%t %s on-l%ne.
/4eratin, costs
Oerat%n6 costs %ncrease 17. oer the re%os ear Ah%ch %s %n-l%ne A%th reene 6roAth.
The %ncrease %n oerat%n6 costs Aas r%mar%l e to the r%s%n6 ener6 costs, cost o e %nts,
emloee costs an maret%n6 eCenses. In orer to m%t%6ate ener6 costs, the $omanocse on %mlement%n6 Oen "ccess PoAer at all o %ts In%an =ac%l%t%es. "t the en o =13,
the $oman Aas st%ll %n the rocess o %mlement%n6 the sstem t %n%she %mlementat%on %n
@1=14.
E5IDTA
#BIDT" %ncrease 7.9 rom !s. 80. $r %n =12 to !s. 87.08 $r. %n =13 altho6h the
asolte mar6%n ell 95 s to 11.35 %n =13. Th%s Aas r%mar%l e tAo reasons.
=%rst, %nstea o s%n6 %ts a%t%onal "PIs or cat%e consmt%on, the $oman sol more "PIs
%n =13 Ah%ch has a loAer ro%t mar6%n than =ormlat%ons. Secon, the $omanFs =ormlat%on#Cans%on Aas elae %n =13 an ace scale- %sses ater %ts comlet%on. The $oman
ha a%t%onal eCenses %ncl%n6 %ncrease manoAer at the ac%l%t A%thot a concrrent
%ncrease %n roct%on.
Interest
Interest l%a%l%t %ncrease 4.0 rom J17.0 $r. %n =12 to J17.7 $r. %n =13 conse/ent to an
%ncrease %n the $omanFs et ortol%o. (h%le there Aas an %ncrease, the %nterest coer 6ot
stren6thene rom 4.8C to 4.9C oer the same er%o, relect%n6 the $omanFs a%l%t to rea
%ts %nterest l%a%l%t%es.
6et 4roit
The $oman earne a net ro%t o !s. 32. $r. %n =13 s. !s. 30.0 $r. %n =12, an %ncrease
o 8.7. In l%ne A%th the net ro%t, the as%c earn%n6s er share %ncrease rom !s. 14.93 to !s.
s1.21 oer the same er%o.
-
8/12/2019 CIPLA LTD for Brief case analysis
10/10
De&t Reconciliation (Rs7 Cr)